Skip to main content

Celularity Inc

For the period ended Mar 31, 2026. Filed Sep 29, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed Sep 29, 2026

CELU$0.76+4.8%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. Exhibits

Exhibit NumberDescription
10.1Form of Securities Purchase Agreement, (incorporated by reference to Exhibit 10.1 to the current report on Form 8-K, filed with the Commission on July 22, 2025).
10.2Form of Warrant Adjustment Agreement (incorporated by reference to Exhibit 10.2 to the current report on Form 8-K, filed with the Commission on July 22, 2025).
10.3Amended and Restated Starr Warrant dated March 17, 2023 (incorporated by reference to Exhibit 10.1 to the current report on Form 8-K/A, filed with the Commission on July 29, 2025).
10.4Amended and Restated Starr Warrant dated March 17, 2023 (incorporated by reference to Exhibit 10.2 to the current report on Form 8-K/A, filed with the Commission on July 29, 2025).
10.5Starr Warrant dated February 12, 2025 (incorporated by reference to Exhibit 10.3 to the current report on Form 8-K/A, filed with the Commission on July 29, 2025).
10.6Amended and Restated RWI Warrant dated June 20, 2023 (incorporated by reference to Exhibit 10.4 to the current report on Form 8-K/A, filed with the Commission on July 29, 2025).
10.7Amended and Restated RWI Warrant Tranche 2 Warrant dated January 16, 2024 (incorporated by reference to Exhibit 10.5 to the current report on Form 8-K/A, filed with the Commission on July 29, 2025).
10.8Amended and Restated RWI Warrant dated March 13, 2024 (incorporated by reference to Exhibit 10.6 to the current report on Form 8-K/A, filed with the Commission on July 29, 2025).
10.9RWI Warrant dated July 24, 2025 (incorporated by reference to Exhibit 10.7 to the current report on Form 8-K/A, filed with the Commission on July 29, 2025).
10.10Form of Securities Purchase Agreement (incorporated by reference to Exhibit 10.1 to the current report on Form 8-K, filed with the Commission on July 30, 2025).
10.11Form of Warrant (incorporated by reference to Exhibit 10.2 to the current report on Form 8-K, filed with the Commission on July 30, 2025).
10.12Form of Promissory Note (incorporated by reference to Exhibit 10.1 to the current report on Form 8-K, filed with the Commission on August 1, 2025).
10.13Form of Warrant (incorporated by reference to Exhibit 10.2 to the current report on Form 8-K, filed with the Commission on August 1, 2025).
31.1Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INSInline XBRL Instance Document- the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document
101.SCHInline XBRL Taxonomy Extension Schema Document
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document
101.LABInline XBRL Taxonomy Extension Label Linkbase Document
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104The cover page for the Company’s quarterly report on Form 10-Q has been formatted in Inline XBRL and contained in Exhibit 101
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.